Aubrey, D A <br/><br/>
The effect of 17-alpha-hydroxy-19-norprogesterone caproate (SH582) on benign prostatic hypertrophy.  [electronic resource] 

 -  The British journal of surgery  Sep 1971 
 - 648-52 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0007-1323 
<br/><br/><label>Standard No.: </label>10.1002/bjs.1800580904  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acid Phosphatase--blood<br/>Aged<br/>Clinical Trials as Topic<br/>Drug Hypersensitivity<br/>Humans<br/>Injections, Intramuscular<br/>Male<br/>Middle Aged<br/>Organ Size<br/>Placebos<br/>Pregnanes--adverse effects<br/>Progestins--adverse effects<br/>Prostate--diagnostic imaging<br/>Prostatic Hyperplasia--drug therapy<br/>Pyuria--complications<br/>Thyroid Gland--drug effects<br/>Urinary Catheterization<br/>Urography